Molecular Medicine

, Volume 14, Issue 7–8, pp 361–364 | Cite as

Molecular Medicine Successes in Neuroscience

  • Bernhard Schaller
  • Jan F. Cornelius
  • Nora Sandu


In this issue of Molecular Medicine, Irvine et al. (1) expound upon the application of molecular biology in clinical medicine and the enabling of targeted interactions at a molecular level over the past decade. In neuroscience, this entails specific interactions with neurons and glial cells. Examples of current research include technologies designed to allow better interaction with neural cells, advanced molecular imaging, materials and hybrid molecules used in neural regeneration, pharmacological neuroprotection, and targeted delivery of drugs and small molecules across the blood-brain barrier. Currently, the most popular molecular medicine topic in neuroscience is the use of molecular imaging techniques. Research on cellular changes has shed invaluable new light on the pathophysiology and biochemistry of neurological diseases. Clinical and experimental use of molecular imaging methods is expanding and now allows quantitative assessment. Molecular imaging may therefore...


  1. 1.
    Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM. (2008) Protein aggregation in the brain: the molecular basis for Alzheimer’s and Parkinson’s Disease. Mol. Med. 14:451–464.CrossRefGoogle Scholar
  2. 2.
    Schaller BJ, Modo M, Buchfelder M. (2007) Molecular imaging of brain tumors: a bridge between clinical and molecular medicine? Mol. Imaging Biol. 9:60–71.CrossRefGoogle Scholar
  3. 3.
    Jacobs AH, et al. (2003) PET-based molecular imaging in neuroscience. Eur. J. Nucl. Med. Mol. Imaging 30:1051–6.CrossRefGoogle Scholar
  4. 4.
    Herholz K, Heiss WD. (2004) Positron emission tomography in clinical neurology. Mol. Imaging Biol. 6:239–69.CrossRefGoogle Scholar
  5. 5.
    Hoehn M, Himmelreich U, Kruttwig K, Wiedermann D. (2008) Molecular and cellular MR imaging: potentials and challenges for neurological applications. J. Magn. Reson. Imaging 27:941–54.CrossRefGoogle Scholar
  6. 6.
    Schaller B. (2005) Positron emission tomography in neuroscience. An integrative part of clinical diagnostic methods and experimental research [in German]. Radiologe 45:186, 188–96.Google Scholar
  7. 7.
    Schaller B. (2008) Strategies for molecular imaging dementia and neurodegenerative diseases. Neuropsychiatr. Dis. Treat 4:585–612.CrossRefGoogle Scholar
  8. 8.
    Schaller BJ, Buchfelder M. (2006) Neuroprotection in primary brain tumors: sense or nonsense? Exp. Rev. Neurother. 6:723–30.CrossRefGoogle Scholar
  9. 9.
    Schaller B. (2003) Neuroprotection in brain tumors: good sense or nonsense from the pathophysiological viewpoint? Nervenarzt 74:1134–6.CrossRefGoogle Scholar
  10. 10.
    Schaller B. (2004) Usefulness of positron emission tomography in diagnosis and treatment follow-up of brain tumors. Neurobiol. Dis. 15:437–48.CrossRefGoogle Scholar
  11. 11.
    Young H, et al. (1999) Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur. J. Cancer 35:1773–82.CrossRefGoogle Scholar
  12. 12.
    O’Doherty MJ, et al. (1997) PET scanning and the human immunodeficiency virus-positive patient. J. Nucl. Med. 38:1575–83.PubMedGoogle Scholar
  13. 13.
    Heiss WD, et al. (2001) Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 124(Pt 1):20–9.CrossRefGoogle Scholar
  14. 14.
    Guadagno JV, Calautti C, Baron JC. (2003) Progress in imaging stroke: emerging clinical applications. Br. Med. Bull. 65:145–57.CrossRefGoogle Scholar
  15. 15.
    Furlan M, et al. (1996) Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann. Neurol. 40:216–26.CrossRefGoogle Scholar
  16. 16.
    Chollet F, et al. (1991) The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann. Neurol. 29:63–71.CrossRefGoogle Scholar
  17. 17.
    Blank SC, et al. (2003) Speech production after stroke: the role of the right pars opercularis. Ann. Neurol. 54:310–20.CrossRefGoogle Scholar
  18. 18.
    Morrish PK, Sawle GV, Brooks DJ. (1996) An [18F]dopa-PET and clinical study of the rate of progression in Parkinson’s disease. Brain 119: 585–91.CrossRefGoogle Scholar
  19. 19.
    Whone AL, et al. (2003) Plasticity of the nigropallidal pathway in Parkinson’s disease. Ann. Neurol. 53:206–13.CrossRefGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2008

Authors and Affiliations

  • Bernhard Schaller
    • 1
    • 2
  • Jan F. Cornelius
    • 1
  • Nora Sandu
    • 1
  1. 1.Department of NeurosurgeryUniversity Hospital LariboisièreParisFrance
  2. 2.University of HelsinkiHelsinkiFinland

Personalised recommendations